AfoliOpen Afoli →

Ustekinumab

Ustekinumab is an active ingredient of the class «immunosuppressive drug».

Open in Afoli Medicines →

Pharmaceutical drug

Informational only — not medical advice. Ask a doctor or pharmacist; never change a dose on your own.

What it is used for

Ustekinumab is a human interleukin-12 and -23 antagonist indicated for the treatment of: Moderate to severe plaque psoriasis in adults and pediatric patients 6 years of age and older who are candidates for phototherapy or systemic therapy.

US label

Plaque psoriasis Yesintek is indicated for the treatment of moderate to severe plaque psoriasis in adults who failed to respond to, or who have a contraindication to, or are intolerant to other systemic therapies including ciclosporin, methotrexate (MTX) or PUVA (psoralen and…

EMA

How it works

Class: immunosuppressive drug

Common side effects

The following serious adverse reactions are discussed elsewhere in the label: Infections Malignancies Serious Hypersensitivity Reactions Posterior Reversible Encephalopathy Syndrome (PRES) Noninfectious Pneumonia Most common adverse reactions are: Psoriasis and Psoriatic Arthritis (≥3%): nasopharyngitis, upper…

US label

Who should not take it

Ustekinumab is contraindicated in patients with clinically significant hypersensitivity to any ustekinumab product or to any of the excipients in Ustekinumab.

US label

Pregnancy and breastfeeding

Available data from the Organization of Teratology Information Specialists (OTIS)/MotherToBaby Ustekinumab Pregnancy Registry, published literature and pharmacovigilance in pregnant women have not identified a Ustekinumab-associated risk of major birth…

Excerpts from the US prescribing label (public domain), copied without changes.

Brand names

United States

Stelara

European Union

Fymskina · Imuldosa · Otulfi · Stelara · Steqeyma · Usgena · Usrenty · Usymro · Uzpruvo · Wezenla · Yesintek

Canada

Finlius · Finlius I.v. · Imuldosa · Jamteki · Jamteki I.v. · Otulfi · Otulfi I.v. · Pyzchiva I.v. · Stelara · Stelara I.v. · Steqeyma · Wezlana · Wezlana I.v. · Yesintek · Yesintek I.v.

Approval status

US Food and Drug Administration
prescription · since 2009
European Medicines Agency
authorised · since 2009
Health Canada
prescription · marketed
First approval anywhere
2009

Codes

ATC
L04AC05
RxNorm CUI
847083
ChEMBL
CHEMBL1201835
UNII
FU77B4U5Z0
Wikidata
Q420305

Frequently asked questions

What is Ustekinumab used for?

Ustekinumab is used for: Plaque psoriasis, Crohn's disease, Ulcerative colitis, Arthritis, Psoriatic arthritis, Ankylosing spondylitis, Psoriasis, and Immune disorder.

What kind of medicine is Ustekinumab?

Ustekinumab is an active ingredient of the class «immunosuppressive drug».

What are the brand names of Ustekinumab?

Brand names of Ustekinumab include Stelara, Fymskina, Imuldosa, Otulfi, Steqeyma, Usgena, Usrenty, and Usymro.

Medicines in the same class

Sources and licences

Updated November 15, 2026